DIOD PAO

DIOD PAO Debt Growth

The Year-over-Year Debt Growth of DIOD PAO (DIOD.ME) as of Nov 18, 2026 is 24.23 %. In the previous year, Year-over-Year Debt Growth was -6.82 % — a change of -454.97% (higher).

Debt Growth

24.23 %

YoY

-454.97%

Last updated:

Year-over-Year Debt Growth of DIOD PAO is 2023 24.23 % . Year-over-Year Debt Growth of DIOD PAO was 2022 -6.82 % . It decreases by -454.97% higher compared to the previous year.

The DIOD PAO Debt Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt Growth
Date
Debt Growth
Jan 1, 2016
-22.72 RUB
Jan 1, 2017
216.86 RUB
Jan 1, 2018
28.98 RUB
Jan 1, 2019
-41.12 RUB
Jan 1, 2020
4.60 RUB
Jan 1, 2021
6.82 RUB
Jan 1, 2022
-6.82 RUB
Jan 1, 2023
24.23 RUB
The DIOD PAO Debt Growth history
YEARDebt GrowthYoY
24.23 %-454.97%
-6.82 %-200.03%
6.82 %+48.42%
4.60 %-111.18%
-41.12 %-241.90%
28.98 %-86.64%
216.86 %-1,054.50%
-22.72 %-76.09%
-95.01 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

DIOD PAO Stock analysis

What does DIOD PAO do? DIOD PAO generates revenue through the manufacturing and sale of pharmaceuticals, dietary supplements, medical cosmetic products, and medical equipment. Its product portfolio includes iodine, selenium, and calcium-based vitamins, as well as silver water purifiers and light therapy apparatus. The company serves healthcare providers, consumers, and medical centers like Mir ekologii, which it owns, through its subsidiaries and affiliated companies. Revenue streams are derived from direct sales of these products and services to end-users and healthcare institutions. The company's main focus is on eco-friendly and natural-based products, targeting consumers seeking health and wellness solutions. Its subsidiaries and affiliated companies facilitate distribution across various segments, including pharmaceuticals, dietary supplements, and medical equipment. The firm's medical center Mir ekologii complements its product offerings by providing healthcare services that align with its natural health focus. DIOD PAO's revenue model relies on the production and sale of its branded products, such as iodine, selenium, and calcium-based vitamins, which are sold through its subsidiaries. The medical equipment segment, including silver water purifiers and light therapy apparatus, contributes to its revenue through direct consumer and institutional sales. The ownership of Mir ekologii allows the company to integrate healthcare services with its product portfolio, enhancing customer retention and cross-selling opportunities. DIOD PAO is one of the most popular companies on Eulerpool.

Frequently Asked Questions about DIOD PAO stock

Year-over-Year Debt Growth of DIOD PAO is 24.23 % in 2023.

On Eulerpool you can find the complete historical development of Year-over-Year Debt Growth DIOD PAO since 2006 – with annual values, charts, and detailed analysis.

Debt growth measures the percentage change in total debt. Rising debt growth should be compared with revenue and earnings growth to assess sustainability.

To evaluate Year-over-Year Debt Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Debt Growth.

Year-over-Year Debt Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Debt Growth's DIOD PAO historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — DIOD PAO

All Key Metrics — DIOD PAO